gms | German Medical Science

56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)
3èmes journées françaises de Neurochirurgie (SFNC)

Deutsche Gesellschaft für Neurochirurgie e. V.
Société Française de Neurochirurgie

07. bis 11.05.2005, Strasbourg

Lectures 11.05.
11.05.-13 Free Subjects - Vascular Neurosurgery, Vasospasms

Meeting Abstract (11.05.-13.01)

Time course of cerebral vasospasm in the rat "double subarachnoid hemorrhage" model determined by selective angiography (DSA), perfusion weighted (PWI) magnet resonance imaging (MRI), and neurological score

Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Zanella FE, Seifert V
[Full Text]
Meeting Abstract (11.05.-13.02)

Arteriovenous differences and transcranial doppler sonography in the monitoring of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Oertel M, Dabelow G, Krause M, Scharbrodt W, Böker DK, Deinsberger W
[Full Text]
Meeting Abstract (11.05.-13.03)

Cisternal CSF of SAH-patients induces endothelial cytosolic calcium oscillation via endoplasmic reticulum Ca2+ -ATPase

Scharbrodt W, Schäfer C, Böker DK, Piper HM, Deinsberger W
[Full Text]
Meeting Abstract (11.05.-13.04)

The selective endothelin A (ETA ) receptor antagonist clazosentan not only reduces the incidence of angiographic vasospasm, but also prevents and reverses symptomatic vasospasm following severe subarachnoid hemorrhage

Barth M, Capelle HH, Münch E, Thomé C, Woitzik J, Tüttenberg J, Fiedler F, Schmiedek P, Vajkoczy P
[Full Text]
Meeting Abstract (11.05.-13.05)


Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P
[Full Text]
Meeting Abstract (11.05.-13.06)

Clazosentan, a novel selective endothelin A receptor antagonist, prevents cerebral hypoperfusion during the acute phase of massive experimental SAH

Schubert GA, Schilling L, Schmiedek P, Thomé C
[Full Text]
Meeting Abstract (11.05.-13.07)

Cerebrovascular characterization of clazosentan, the first non-peptide Endothelin-receptor antagonist clinically effective for the treatment of cerebral vasospasm

Vatter H, Zimmermann M, Tesanovic V, Raabe A, Seifert V, Schilling L
[Full Text]
Meeting Abstract (11.05.-13.08)

The family of methylated L-arginines (L-NMMA, ADMA and SDMA)

Jung CS, Pluta RM, Oldfield EH
[Full Text]
Meeting Abstract (11.05.-13.09)

Ultraearly reperfusion induces blood brain barrier disruption during focal ischemia in rats

Woitzik J, Hohenstein A, Weinzierl N, Schilling L
[Full Text]
Meeting Abstract (11.05.-13.10)

Ischemic events after endovascular treatment of unruptured aneurysms

Grunwald IQ, Papanagiotou P, Struffert T, Roth C, Dorenbeck U, Krick C, Politi M, Reith W
[Full Text]
Meeting Abstract (11.05.-13.11)

Balloon angioplasty resolves perfusion/diffusion mismatch on MRI and prevents tissue at risk from vasospastic infarction after subarachnoid hemorrhage

Beck J, Raabe A, Lanfermann H, Weidauer S, Seifert V
[Full Text]